Previous 10 | Next 10 |
Shares of Perrigo (NYSE: PRGO) were jumping 9.6% higher as of 3:13 p.m. EST on Thursday. The solid gain came after the healthcare company reported better-than-expected, third-quarter earnings results after the market closed on Wednesday. Perrigo announced adjusted earnings o...
Perrigo ([[PRGO]] +7.4%) Q3 consolidated net sales were $1.2B, an increase of 1.3% vs. previous year, misses consensus by $30M.Q4 EPS estimate of $1.03 and revenue estimate of $1.35B.Worldwide consumer Q3 net sales grew 3.6% compared to the prior year. Organic net sales grew 1.6%.Co...
Most stocks have recovered nicely from the market meltdown earlier this year, but not Perrigo (NYSE: PRGO) . Although the company's share price rebounded along with the overall stock market, it's now again close to the low point it hit in March. Investors wondering if Perrigo wo...
Perrigo Company plc (PRGO) Q3 2020 Earnings Conference Call November 04, 2020 16:30 ET Company Participants Brad Joseph - Vice President, Global Investor Relations & Corporate Communications Murray Kessler - President & Chief Executive Officer Ray Silcock - Chief Financial Officer Con...
Perrigo (PRGO): Q3 Non-GAAP EPS of $0.93 beats by $0.07; GAAP EPS of -$1.13 misses by $1.48.Revenue of $1.2B (+0.8% Y/Y) misses by $30M.FY 2020 guidance: Net sales growth of 6% to 7% with organic net sales growth of at least 3%. Adjusted diluted EPS of $3.95-$4.15 vs consensus of $4.07. ...
Perrigo Reports Third Quarter 2020 Financial Results Consolidated Third Quarter Net Sales Grew 1.3%(1) Led by CSCA Organic(2) Net Sales Growth of 4.0% GAAP ("Reported") Third Quarter Net Loss Per Diluted Share of $1.13 Non-GAAP ("Adjusted") Third Quarter Earnings Per Dil...
Irish High Court Rules Perrigo's Legitimate Expectations Not Violated; Company Remains Committed To Vigorously Challenging The Notice Of Amended Assesment Judicial Review was one pathway available to the Company to obtain relief No payment required as a result of the ruling ...
Perrigo (NYSE:PRGO) is scheduled to announce Q3 earnings results on Wednesday, November 4th, before market open.The consensus EPS Estimate is $0.86 (-17.3% Y/Y) and the consensus Revenue Estimate is $1.23B (+3.4% Y/Y).Over the last 2 years, PRGO has beaten EPS estimates 75% of the time and ha...
Perrigo Completes Acquisition Of Market-Leading OTC Self-Care Brands In Eastern Europe PR Newswire DUBLIN, Nov. 2, 2020 DUBLIN , Nov. 2, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affo...
Travel Safely with Steripod® this Holiday Season Steripod® is here to help protect holiday travelers from airborne contaminants PR Newswire ALLEGAN, Mich., Nov. 2, 2020 ALLEGAN, Mich. , Nov. 2, 2020 /PRNewswire/ -- The holiday season feels ...
News, Short Squeeze, Breakout and More Instantly...
Perrigo to Release Second Quarter 2024 Financial Results on August 2, 2024 PR Newswire DUBLIN , July 19, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its secon...
2024-07-19 06:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Perrigo Completes Divestment of HRA Pharma Rare Diseases Business PR Newswire DUBLIN , July 10, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced that it has compl...